MRI Models Predict Early Recurrence of Hepatocellular Carcinoma
New MRI-based models have been developed to predict the early recurrence of hepatocellular carcinoma (HCC). These predictive tools aim to improve patient management by identifying those at higher risk of cancer returning soon after treatment. Early detection of recurrence can guide timely interventions and potentially improve outcomes for HCC patients.
EMJ·



